DT
Douglas Tsao HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
94
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
77.8%
Neutral
22.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $20 |
285%
upside
| 1 | -13% |
0
%
| 9 Jan ‘26 10 days ago |
|
|
|
Buy
Reiterated
| $38 |
98%
upside
| 2 | -8.5% |
0
%
| 9 Jan ‘26 11 days ago |
|
|
|
Neutral
Maintained
| $0.5000 |
8%
downside
| 1 | -42% |
0
%
| 2 Jan ‘26 17 days ago |
|
|
|
Neutral
Reiterated
| $11 |
16%
downside
| 2 | -46% |
0
%
| 26 Dec ‘25 25 days ago |
|
|
|
Buy
Maintained
| $26 |
12%
upside
| 1 | +15% |
0
%
| 12 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $5 |
83%
upside
| 1 | +14% |
0
%
| 12 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $40 |
49%
upside
| 1 | +33% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $340 |
7%
upside
| 4 | +37% |
0
%
| 8 Dec ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $12 |
522%
upside
| 1 | -13% |
0
%
| 2 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $20 |
0%
downside
| 1 | +34% |
0
%
| 11 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $4 |
10%
downside
| 1 | – |
–
| 6 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $45 |
126%
upside
| 1 | -11% |
0
%
| 31 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $915 |
14%
upside
| 1 | +3.8% |
0
%
| 31 Oct ‘25 2 months ago |
|